A detailed history of Russell Investments Group, Ltd. transactions in Celcuity Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 14 shares of CELC stock, worth $185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$185
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$13.74 - $21.6 $192 - $302
14 New
14 $0
Q3 2020

Nov 09, 2020

SELL
$5.1 - $7.07 $822,007 - $1.14 Million
-161,178 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$4.42 - $11.04 $712,406 - $1.78 Million
161,178 New
161,178 $1.11 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $198M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.